Cannara Biotech Inc
XTSX:LOVE
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
C
|
Cannara Biotech Inc
XTSX:LOVE
|
177.5m CAD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
924.3B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.3B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
281.3B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
240.6B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
230.1B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.9B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
151.3B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD |
Loading...
|
Market Distribution
| Min | -9 940 586.9% |
| 30th Percentile | -85.9% |
| Median | -7.8% |
| 70th Percentile | 5.5% |
| Max | 60 777.6% |
Other Profitability Ratios
Cannara Biotech Inc
Glance View
Cannara Biotech, Inc. is a pharmaceutical company, which operates cannabis biotech facility. The company is headquartered in Montreal, Quebec. The company went IPO on 2019-01-14. The firm operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. Its segments include Indoor cannabis operations and Real estate operations. The Indoor cannabis operations segment includes the cultivation, processing and sale of dried cannabis and cannabis derivatives exclusively for the Quebec and Canadian market. The Real estate operations segment is related to the Farnham building. The Company, through ShopCBD.com Inc., operates an online e-commerce platform in the United States hemp-based Cannabidiol (CBD) market. The firm sells dried cannabis products to provincial retail distributors and other licensed producers across Canada through Cannara Biotech (Quebec) Inc. The company owns approximately two cultivation facilities based in Quebec spanning over 1,650,000 square feet.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Cannara Biotech Inc is 10.5%, which is above its 3-year median of 10.4%.
Over the last 3 years, Cannara Biotech Inc’s Net Margin has increased from 7.1% to 10.5%. During this period, it reached a low of 6.9% on May 31, 2024 and a high of 15.1% on May 31, 2025.
